CORDIS · 101007256 · H2020

ALISE Anti-Cancer Light-Controllable Antibody-Peptide Conjugates

Coordinator: ENAMINE LIMITED LIABILITY COMPANY,RESEARCH AND PRODUCTION ENTERPRISE (UA)

Project ALISE (Antibody Light-Induced Selectivity Enhancement) will integrate the expertise, resources and knowledge of participating Institutions focusing on design, synthesis and preclinical study of conjugates of monoclonal antibodies with peptides whose anti-cancer activity can be enhanced in tumours by irradiation with light (LC-APCs). The possibility to boost the anti-cancer activity only in tumours, multiplied by targeting cancer cells by antibodies will be a basis for innovative and safer therapeutic strategies. Four of seven participating Institutions successfully collaborated in the…

EU contribution
€745k
Total cost
€745k
Period
2021-03-01 → 2026-02-28
Framework
Horizon 2020 (2014–2020)
Funding scheme
MSCA-RISE
Call
H2020-MSCA-RISE-2020
Status
SIGNED

About Horizon 2020 (2014–2020)

Horizon 2020 was the EU's flagship research and innovation programme for 2014–2020, with a budget of around €77 billion. It bundled FP7's strands with the EIT and the Competitiveness and Innovation Programme, introduced a stronger societal-challenge orientation, and pushed the funding logic toward closer-to-market innovation. New calls closed in 2020 but funded projects continued through 2024.

EU contribution: €745k awarded to the consortium. The project runs over approximately 5 years from 2021-03-01 to 2026-02-28.

Full record on CORDIS — partners, deliverables, publications, news.

Open on cordis.europa.eu → Grant DOI ↗

Frequently asked questions

Who funds this research project?
This project is funded by the European Union through the Horizon 2020 (2014–2020) programme, under the MSCA-RISE funding scheme.
What is the EU contribution?
The European Commission contributes €745k toward a total project budget of €745k.
Which EU programme funds it?
The project is funded under Horizon 2020 (2014–2020), call H2020-MSCA-RISE-2020.
Who coordinates the project?
The project is coordinated by ENAMINE LIMITED LIABILITY COMPANY,RESEARCH AND PRODUCTION ENTERPRISE (UA).
What is the project timeline?
The project runs from 2021-03-01 to 2026-02-28 — approximately 5 years.
Where can I find the full project record?
The complete record — partners, deliverables, publications and news — is published on CORDIS under project ID 101007256.